People · Operator
Named in public records as an officer, director or promoter · active 2017–2021 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Contraline, Inc. | — | Biotechnology | Series A | $7.2M | $189.4M | 2021 |
| FundRx, Inc. | — | Other Health Care | Seed | $1.4M | $34.5M | 2017 |
Gurdane Bhutani at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gurdane Bhutani on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael King | 1 | 6 |
| Zeshan Muhammedi | 1 | 2 |
| Martin Emerson | 1 | 2 |
| Aziz Jainal Hashim | 1 | 1 |
| Kevin Eisenfrats | 1 | 1 |
| Tom Thorpe | 1 | 1 |
| Mohammad Jainal Bhuiyan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.